ACQUISITION OF THE ANTITUBERCULOSIS PHARMACEUTICAL PRODUCT LEVOFLOXACIN 250 MG TABLETS

The National Center for the Supply of Strategic Health Resources (CENARES), under the Ministry of Health (MINSA), is conducting a public tender for the acquisition of Levofloxacin 250 mg tablets. This pharmaceutical product is an essential antituberculosis medication, playing a critical role in the treatment regimens for tuberculosis (TB) in Peru. The procurement aims to ensure a sufficient and timely supply of this vital drug to healthcare facilities across the country, supporting the national efforts to combat tuberculosis. Ensuring the availability of quality-assured antitubercular drugs is a cornerstone of public health policy, particularly for a disease like TB which requires consistent and prolonged treatment. The tender is being carried out as a Public Tender (Licitación Pública), identified by process number LP-SM-27-2025-CENARES/MINSA-1. This acquisition is crucial for maintaining the continuity of treatment for TB patients and contributing to the overall public health objectives within the Lima Department and nationwide.

This is a supplies contract in the governance and public administration sector. Located in Peru, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of PEN 960,000.

Published through Peru SEACE, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.